epigallocatechin gallate has been researched along with Bone Cancer in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dong, C; Shen, P; Wang, H; Wang, J; Wang, Z | 1 |
| Bose, S; Kushram, P; Majumdar, U | 1 |
| Chen, D; Wang, W; Zhu, K | 1 |
| He, A; He, X; Jiang, L; Tao, C | 1 |
| Chen, B; Chen, J; Chen, X; Chen, Y; Qian, H; Tang, G; Wang, Y; Zhang, Z | 1 |
| Li, Q; Zhang, X | 1 |
| Guo, W; Han, X; Lu, XC; Peng, CL; Ren, TT; Tang, GQ; Yan, TQ; Zhao, FL; Zhao, H | 1 |
| Jenabi, JM; Kang, HG; Liu, XF; Reynolds, CP; Sorensen, PH; Triche, TJ | 1 |
| Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Axanova, L; Morré, DJ; Morré, DM | 1 |
| Goldberg, VM; Haqqi, TM; Islam, N; Islam, S; Johnstone, B; Kermode, T; Malemud, CJ; Moskowitz, RW; Mukhtar, H | 1 |
11 other study(ies) available for epigallocatechin gallate and Bone Cancer
| Article | Year |
|---|---|
Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt/β-catenin signalling pathway.
Topics: Animals; Apoptosis; beta Catenin; Bone Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Osteosarcoma; Wnt Signaling Pathway | 2022 |
Hydroxyapatite coated titanium with curcumin and epigallocatechin gallate for orthopedic and dental applications.
Topics: Anti-Bacterial Agents; Bone Neoplasms; Curcumin; Durapatite; Humans; Osteosarcoma; Titanium | 2023 |
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.
Topics: Animals; Apoptosis; Autophagy; Biomarkers; Bone Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Disease Models, Animal; Doxorubicin; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Neoplastic Stem Cells; Osteosarcoma; Receptor, Notch3; RNA, Long Noncoding; Xenograft Model Antitumor Assays | 2018 |
Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate.
Topics: Apoptosis; Bone Neoplasms; Catechin; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Humans; MicroRNAs; Osteosarcoma; Tumor Cells, Cultured | 2014 |
(-)-Epigallocatechin-3-gallate inhibits osteosarcoma cell invasiveness by inhibiting the MEK/ERK signaling pathway in human osteosarcoma cells.
Topics: Bone Neoplasms; Catechin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Osteosarcoma | 2015 |
Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal Tumor Necrosis Factor-α expression in a mouse model.
Topics: Animals; Behavior, Animal; Bone Neoplasms; Catechin; Disease Progression; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Osteosarcoma; Pain Measurement; Pain, Intractable; Spinal Cord; Spine; Tumor Necrosis Factor-alpha | 2015 |
(-)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells.
Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Catechin; Cell Death; Cell Division; Cell Survival; Chondrosarcoma; DNA Primers; Flow Cytometry; Gene Amplification; Humans; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface | 2010 |
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells.
Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Catechin; Cell Adhesion; Cell Death; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Humans; MAP Kinase Signaling System; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphorylation; Receptor, IGF Type 1; Sarcoma, Ewing | 2010 |
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
Growth of LNCaP cells in monoculture and coculture with osteoblasts and response to tNOX inhibitors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Bone Neoplasms; Capsaicin; Catechin; Cell Survival; Cisplatin; Humans; Isoflavones; Male; Osteoblasts; Paclitaxel; Plant Extracts; Prostatic Neoplasms; Tumor Cells, Cultured | 2005 |
Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Caspase 3; Caspases; Catechin; Cell Survival; Chondrosarcoma; Cysteine Proteinase Inhibitors; Humans; Kinetics; Tumor Cells, Cultured | 2000 |